Dr. Byron P. Vaughn, MD

Dr. Vaughn practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Vaughn's NPI, 1255503223, was assigned on March 30, 2008. Dr. Vaughn graduated from Drexel University College Of Medicine in 2008. Dr. Vaughn's Minnesota license number on file is 57931.

Dr. Vaughn's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Vaughn's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Vaughn is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Vaughn to 9 more medical groups, 7 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaughn practices, 10 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vaughn's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Vaughn is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Vaughn's licenses on file in 2 states: Minnesota and Massachusetts.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy, intestinal or bowel obstruction and upper GI endoscopy among the conditions Dr. Vaughn treats.

CMS data shows 14 Medicare services from Dr. Vaughn across 1 procedure code in 2024, all of them office visits, for 48 Medicare patients. Medicare paid $1,390 for them. Every service was in an office.

CMS counts 48 Medicare patients who saw Dr. Vaughn in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 63% have high cholesterol. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaughn's median patient age at 49, with 50% women.

In 2024, Dr. Vaughn wrote 78 Medicare Part D claims for 37 patients. 73% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $3,059 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Vaughn for performance year 2024, reported as part of a group. Dr. Vaughn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaughn as offering telehealth. CMS counts 31 procedures of colonoscopy by Dr. Vaughn, more than 54% of the clinicians it reports for that procedure.

Dmand AI links 95 papers to Dr. Vaughn, published from 2011 to 2025. 2017 was the busiest year, with 9. The most frequent topics are Fecal Microbiota Transplantation, Inflammatory Bowel Diseases and Clostridium Infections. Dr. Vaughn has published most often in Inflamm Bowel Dis. Dr. Vaughn's most frequent co-authors are Alexander Khoruts, MD, Adam S. Cheifetz, MD and Monika Fischer, MD.

CMS Open Payments shows 194 general payments to Dr. Vaughn from 4 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 73% of the total. Abbvie Inc. paid the most, $119,958. It also lists 2 research payments totaling $7,017 from 2017 to 2023.

Dr. Vaughn graduated from Drexel University College Of Medicine in 2008.

Dr. Vaughn is in network with 12 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.